EXAM 1- W/O Prototypes

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/328

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

329 Terms

1
New cards

TYPES OF PAIN

• Acute pain

• Chronic pain

• Neuropathic pain

• Nociceptive pain

• Radicular pain

2
New cards

Opioid agonists:

• Morphine, fentanyl, meperidine, hydromorphone, and methadone

3
New cards

Opioid agonistsantagonists:

Butorphanol

4
New cards

DUAL-MECHANISM ANALGESIC AGENTS Ex

Tramadol

5
New cards

DUAL-MECHANISM ANALGESIC AGENTS MOA

•Binds with low affinity to mu receptors in the CNS

•Prevents the reuptake of norepinephrine and serotonin

6
New cards

DUAL-MECHANISM ANALGESIC AGENTS CI

•Manage moderate to moderately severe pain, both acute and chronic

7
New cards

DUAL-MECHANISM ANALGESIC AGENTS SE

•Sedation, dizziness, headache, nausea, and constipation

8
New cards

DUAL-MECHANISM ANALGESIC AGENTS ADR

•Seizures, urinary retention, serotonin syndrome, mania (w/SSRIs), respiratory depression, addiction, and toxicity

9
New cards

DUAL-MECHANISM ANALGESIC AGENTS Ed

•Basics

•Constipation – increase their fluid and fiber intake, as well as activity and exercise

•Monitor respiratory rate

•Avoid abrupt cessation (serotonin effect)

10
New cards

OPIOID ANTAGONISTS Ex

Naloxone

11
New cards

OPIOID ANTAGONISTS MOA

• Competitively binds to the opioid receptors in the central and peripheral nervous systems

• Prevent opioid agonists from exerting their effects

12
New cards

OPIOID ANTAGONISTS CI

• Reverses opioid toxicity (very short acting/redose q20 mins)

• Prevention of EtOH/opioid relapse

• Opioid induced constipation

13
New cards

OPIOID ANTAGONISTS SE

• Acute withdrawal (nausea, vomiting, diarrhea, abdominal pain, anxiety, aggression, and runny nose)

14
New cards

OPIOID ANTAGONISTS ADR

• V-tach

• Pulmonary edema

15
New cards

OPIOID ANTAGONISTS Ed

• Basics

• Watch for withdrawal manifestations

16
New cards

NONOPIOID ANALGESICS Ex Acetaminophen

Acetaminophen

17
New cards

NONOPIOID ANALGESICS MOA Acetaminophen

• Interferes with COX mechanism in the CNS w/o effective peripheral tissues

• Interrupts PG production in the CNS while stimulating serotonin pathway

18
New cards

NONOPIOID ANALGESICS CI Acetaminophen

• Reduces mild to moderate pain and fever

19
New cards

NONOPIOID ANALGESICS SE Acetaminophen

• GI upset and itching may occur

20
New cards

NONOPIOID ANALGESICS ADR Acetaminophen

• Liver damage

• Nephrotoxicity, acute generalized exanthematous pustulosis, necrolysis, and Stevens-Johnson syndrome

21
New cards

NONOPIOID ANALGESICS Ed Acetaminophen

• Basics

• Avoid EtOH consumption before, during or after taking acetaminophen

22
New cards

NONOPIOID ANALGESICS Ex Asprin/Ibuprofen

Asprin/Ibuprofen

23
New cards

NONOPIOID ANALGESICS MOA Asprin/Ibuprofen

•Blocks COX1 & COX2

24
New cards

NONOPIOID ANALGESICS CI Asprin/Ibuprofen

• Reduces inflammation, pain and fever

25
New cards

NONOPIOID ANALGESICS SE Asprin/Ibuprofen

•Ibuprofen:

•Common side effects are heartburn, dyspepsia, nausea, and vomiting. Long-term use at high doses can significantly increase the risk of developing stomach ulcers.

•Aspirin:

•Common side effects include nausea, epigastric upset, and dyspepsia.

26
New cards

NONOPIOID ANALGESICS ADR Asprin/Ibuprofen

•GI bleeding, kidney problems, increased blood pressure, allergic reactions, tinnitus, and dermatological reactions

27
New cards

NONOPIOID ANALGESICS Ed Asprin/Ibuprofen

•Basics

•Instruct clients to tell the provider about a history of allergies to NSAIDs, GI bleeding or ulcerations, kidney problems, asthma, heart failure, heart attack, and pregnancy or possible pregnancy.

•Instruct clients to report manifestations of an allergic reaction, bleeding, increase in blood pressure, difficulty breathing, decreased urine output, swelling, or weight gain.

28
New cards

NONOPIOID ANALGESICS Ex Lidocaine

Lidocaine

29
New cards

NONOPIOID ANALGESICS MOA Lidocaine

• Inhibits nerve impulses by blocking sodium ion transport across the neuronal membrane

30
New cards

NONOPIOID ANALGESICS CI Lidocaine

• Local anesthesia (and dysrhythmia)

31
New cards

NONOPIOID ANALGESICS SE Lidocaine

• Redness, irritation, itching, or rash

32
New cards

NONOPIOID ANALGESICS ADR Lidocaine

• Systemic toxicity

33
New cards

NONOPIOID ANALGESICS Ed Lidocaine

• Basics

• After upper extremity regional blockage, extremity must be secured (tied down)

34
New cards

ADJUVANT ANALGESICS Ex ANTIDEPRESSANT

venlafaxine (SNRI)

35
New cards

ADJUVANT ANALGESICS MOA ANTIDEPRESSANT

• Slows the reuptake of serotonin and norepinephrine in the CNS

• Increases serotonergic activity in the spinal pathway that signals pain

36
New cards

ADJUVANT ANALGESICS CI ANTIDEPRESSANT

• Fibromyalgia, chronic musculoskeletal pain, and neuropathic pain (DM, chemo)

37
New cards

ADJUVANT ANALGESICS SE ANTIDEPRESSANT

• Increased perspiration, decreased appetite, constipation, painful urination, drowsiness, fatigue, and insomnia

38
New cards

ADJUVANT ANALGESICS ADR ANTIDEPRESSANT

• Suicidal ideation (BBW), serotonin syndrome, neuroleptic malignant syndrome, seizures, bleeding, pancreatitis, hepatotoxicity, erythema multiforme, and StevensJohnson syndrome

39
New cards

ADJUVANT ANALGESICS Ed ANTIDEPRESSANT

• Basics

• Advise clients to report new or unexpected behaviors or thoughts, including thoughts of suicide.

• Caution clients not to stop taking this medication abruptly.

40
New cards

ADJUVANT ANALGESICS Ex ANTICONVULSANT

Anticonvulsant- gabapentin

41
New cards

ADJUVANT ANALGESICS MOA ANTICONVULSANT

•Inhibits calcium channels in the brain allowing the release of neurotransmitters

42
New cards

ADJUVANT ANALGESICS CI ANTICONVULSANT

•Nerve pain (neuralgia, neuropathic, and fibromyalgia)

43
New cards

ADJUVANT ANALGESICS SE ANTICONVULSANT

•LOTS: Impaired coordination, weakness, dizziness, vertigo, drowsiness, altered reflexes, and weakness

44
New cards

ADJUVANT ANALGESICS ADR ANTICONVULSANT

•Hypersensitivity reactions, suicidal ideation, Stevens-Johnson syndrome, and rhabdomyolysis

45
New cards

ADJUVANT ANALGESICS Ed ANTICONVULSANT

•Basics

•Caution clients not to stop taking this medication abruptly.

•Advise clients to talk to the provider before taking any new medication and to tell the provider about all over-the-counter medications

46
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE Ex

Weed

47
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE MOA

•CB1 receptors in the brain regulate the neurotransmitters norepinephrine, serotonin, dopamine, and GABA.

•CB2 receptors are located in peripheral tissues and play a role in immune and reduction of inflammatory responses.

48
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE CI

•Reduce chronic pain, neuropathic pain, and the spasms of multiple sclerosis when other conventional treatments are insufficient or have undesirable side effects.

49
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE SE

50
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE

•Dry mouth, nausea (CHS), dizziness, disorientation, euphoria, confusion, sedation, tachycardia, and difficulty breathing

51
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE ADR

•Reversible, acute psychosis, panic attack, and cannabis hyperemesis syndrome

52
New cards

COMPLEMENTARY AND ALTERNATIVE MEDICINE Ed

•Basics

•Advise clients to start with a low dose and increase incrementally until the relief they are seeking is achieved.

•Teach clients to purchase cannabis products from a reputable retail outlet and ask for the quality and purity lab test results.

53
New cards

SEDATIVE-HYPNOTICS Ex

PROPOFOL, ETOMIDATE, AND KETAMINE

54
New cards

SEDATIVE-HYPNOTICS MOA

•Activates the GABA complex in the brain, keeping the GABA channel open longer, allowing greater amounts of chloride to cross the cell membrane

55
New cards

SEDATIVE-HYPNOTICS CI

•Anesthesia induction

•Sedation

56
New cards

SEDATIVE-HYPNOTICS SE

•Sedation, amnesia, respiratory depression, and, potentially, apnea

57
New cards

SEDATIVE-HYPNOTICS ADR

•Hypotension

58
New cards

SEDATIVE-HYPNOTICS Ed

•Inform clients that a nurse will continuously monitor their vital signs and level of consciousness until both have returned to baseline.

•Provide verbal and written instructions as to when they can return to activities such as driving

59
New cards

SYNTHETIC OPIOIDS Ex

FENTANYL

60
New cards

SYNTHETIC OPIOIDS MOA

• Synthetic opioids act on mu receptors in the brain to relieve pain and increase anesthetic depth

61
New cards

SYNTHETIC OPIOIDS CI

• Reducing pain during or after surgical procedures

• Blunting the sympathetic response to intubation

• Suppressing airway reflexes

• Prevent coughing and bronchospasm for laryngoscopy/intubation

62
New cards

SYNTHETIC OPIOIDS SE

• Sedation, dry mouth, headache, and respiratory depression

63
New cards

SYNTHETIC OPIOIDS ADR

• Skeletal muscle (chest wall) rigidity, difficulty breathing, opioid-induced hyperalgesia, allodynia, cardiovascular depression, hypotension that requires intervention, respiratory depression, and adrenal insufficiency

64
New cards

SYNTHETIC OPIOIDS Ed

• No driving for at least 24 hours after the procedure

• Monitoring required before, during, and after procedure

65
New cards

BENZODIAZEPINES Ex

LORAZEPAM

66
New cards

BENZODIAZEPINES MOA

• Increase GABA in the body causing inhibitory effect resulting in CNS depression

67
New cards

BENZODIAZEPINES CI

• Anxiolytic

• Sedation

• “Balanced” anesthesia

68
New cards

BENZODIAZEPINES SE

• NV

• Apnea

69
New cards

BENZODIAZEPINES ADR

Respiratory depression, sedation, coma, and death (w/opioids)

70
New cards

BENZODIAZEPINES Ed

• Monitoring required before, during, after procedure

• Not to take benzodiazepines with other medications that cause CNS depression

71
New cards

BARBITURATES Ex

METHOHEXITAL

72
New cards

BARBITURATES MOA

• Increase GABA in the body causing inhibitory effect resulting in CNS depression

73
New cards

BARBITURATES CI

• Anxiolytic

• Sedation

• “Balanced” anesthesia

74
New cards

BARBITURATES SE

• NV

• Apnea

75
New cards

BARBITURATES ADR

• Respiratory depression, sedation, coma, and death (w/opioids)

76
New cards

BARBITURATES Ed

• Monitoring required before, during, after procedure

• Not to take benzodiazepines with other medications that cause CNS depression

77
New cards

NEUROMUSCULAR BLOCKING AGENTS Ex

SUCCINYLCHOLINE

78
New cards

NEUROMUSCULAR BLOCKING AGENTS MOA

• Mimics acetylcholine, binding to nicotinic receptors and causing continuous depolarization

79
New cards

NEUROMUSCULAR BLOCKING AGENTS CI

• Rapid sequence intubation and short procedures requiring quick onset

80
New cards

NEUROMUSCULAR BLOCKING AGENTS SE

• Hyperkalemia

• Malignant hyperthermia

• Prolonged paralysis

81
New cards

NEUROMUSCULAR BLOCKING AGENTS ADR

• See side effects

• Which patients would not be good candidates for succinylcholine induction?

82
New cards

NEUROMUSCULAR BLOCKING AGENTS Ed

• Emphasize the importance of disclosing any personal or family history of reactions to anesthesia or neuromuscular disorders

83
New cards

NONDEPOLARIZING Ex

ROCURONIUM

84
New cards

NONDEPOLARIZING MOA

• Blocks acetylcholine from binding to its receptors, preventing depolarization and muscle contraction

85
New cards

NONDEPOLARIZING CI

• Suitable for longer surgeries requiring sustained muscle relaxation

86
New cards

NONDEPOLARIZING SE/ADR

• Hypotension

• Bradycardia

87
New cards

NONDEPOLARIZING Ed

• Emphasize the importance of disclosing any personal or family history of reactions to anesthesia or neuromuscular disorders

88
New cards

LIDOCAINE MOA

• Binds to voltage-gated sodium channels to prevent nerves from achieving action potentials

89
New cards

LIDOCAINE CI

• Local anesthesia

• Epidural anesthesia

• Regional anesthesia

• Spinal anesthesia

• Topical anesthesia

90
New cards

LIDOCAINE SE

• Tingling, numbness, and loss of temperature and pressure sensations

91
New cards

LIDOCAINE ADR

• LAST [Local Anesthetic Systemic Toxicity] -> localized nerve damage that can cause temporary or permanent neuropathic pain, numbness, or weakness

92
New cards

LIDOCAINE Ed

• Inform clients of the expected duration of action of the local anesthetic they receive

93
New cards

Types of headaches

• Tension-type headaches

• Migraine headaches

• Cluster headaches

• Sinus headaches

94
New cards

CLASSES OF MEDICATIONS

• Antihistamines

• Beta-blockers

• Calcium channel blockers

Decongestants

Neuromuscular blocking agents

95
New cards

Serotonin receptor agonists:

• Serotonin 5-HT1B/5-HT1D receptor agonists (triptans)

• Serotonin 5-HT1F receptor agonist (ditans)

96
New cards

Live-Attenuated Vaccines:

MMR, varicella

97
New cards

Inactivated Vaccines:

Haemophilus influenzae b, hepatitis A, inactivated poliovirus

98
New cards

mRNA Vaccines:

SARS-CoV2, rotavirus

99
New cards

Indications and contradictions for vaccines

  • • Travel Immunization

  • • School Immunization Requirements

  • • Special Considerations:

    • • Allergies

    • • Pregnancy

    • • Clients who are immunocompromised

100
New cards

What is innate immunity?

The body’s natural, present-at-birth defense that responds immediately to pathogens. Includes barriers, inflammation, phagocytes, and natural killer cells.